Research ArticleArticle
Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis
Martin Rudwaleit, Pascal Claudepierre, Paul Wordsworth, Eduardo Loza Cortina, Joachim Sieper, Martina Kron, Roberto Carcereri-De-Prati, Hartmut Kupper and Sonja Kary
The Journal of Rheumatology March 2009, jrheum.081048; DOI: https://doi.org/10.3899/jrheum.081048
Martin Rudwaleit
Pascal Claudepierre
Paul Wordsworth
Eduardo Loza Cortina
Joachim Sieper
Martina Kron
Roberto Carcereri-De-Prati
Hartmut Kupper
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis
Martin Rudwaleit, Pascal Claudepierre, Paul Wordsworth, Eduardo Loza Cortina, Joachim Sieper, Martina Kron, Roberto Carcereri-De-Prati, Hartmut Kupper, Sonja Kary
The Journal of Rheumatology Mar 2009, jrheum.081048; DOI: 10.3899/jrheum.081048
Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis
Martin Rudwaleit, Pascal Claudepierre, Paul Wordsworth, Eduardo Loza Cortina, Joachim Sieper, Martina Kron, Roberto Carcereri-De-Prati, Hartmut Kupper, Sonja Kary
The Journal of Rheumatology Mar 2009, jrheum.081048; DOI: 10.3899/jrheum.081048